Trial
NCT02720926
Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
National Cancer Centre, Singapore
Collaborators
Novartis
Condition
Colorectal Cancer
Intervention
Xeloda,
Why stopped
Unafavourable toxicity profile
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-28